These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 27304054)

  • 1. Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer.
    Deng J; Wang L; Chen H; Hao J; Ni J; Chang L; Duan W; Graham P; Li Y
    Oncotarget; 2016 Aug; 7(34):55771-55788. PubMed ID: 27304054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
    Glackin CA
    Enzymes; 2018; 44():83-101. PubMed ID: 30360816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.
    Nakamura K; Terai Y; Tanabe A; Ono YJ; Hayashi M; Maeda K; Fujiwara S; Ashihara K; Nakamura M; Tanaka Y; Tanaka T; Tsunetoh S; Sasaki H; Ohmichi M
    Oncol Rep; 2017 Jun; 37(6):3189-3200. PubMed ID: 28440503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer stem cells in colon cancer].
    Pannequin J
    Bull Cancer; 2017 Dec; 104(12):1072-1074. PubMed ID: 29153380
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions.
    Davidson B; Holth A; Hellesylt E; Tan TZ; Huang RY; Tropé C; Nesland JM; Thiery JP
    Hum Pathol; 2015 Jan; 46(1):1-8. PubMed ID: 25455994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial ovarian cancer stem cells: underlying complexity of a simple paradigm.
    Garson K; Vanderhyden BC
    Reproduction; 2015 Feb; 149(2):R59-70. PubMed ID: 25301968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian cancer spheroids.
    He M; Wang D; Zou D; Wang C; Lopes-Bastos B; Jiang WG; Chester J; Zhou Q; Cai J
    Oncotarget; 2016 Dec; 7(52):86374-86387. PubMed ID: 27863439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer.
    Ahmed N; Abubaker K; Findlay J; Quinn M
    Curr Cancer Drug Targets; 2010 May; 10(3):268-78. PubMed ID: 20370691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.
    Latifi A; Abubaker K; Castrechini N; Ward AC; Liongue C; Dobill F; Kumar J; Thompson EW; Quinn MA; Findlay JK; Ahmed N
    J Cell Biochem; 2011 Oct; 112(10):2850-64. PubMed ID: 21618587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer stem cell markers: prognostic and therapeutic implications.
    Burgos-Ojeda D; Rueda BR; Buckanovich RJ
    Cancer Lett; 2012 Sep; 322(1):1-7. PubMed ID: 22334034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer.
    Huang RY; Chung VY; Thiery JP
    Curr Drug Targets; 2012 Dec; 13(13):1649-53. PubMed ID: 23061545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell pathways contribute to clinical chemoresistance in ovarian cancer.
    Steg AD; Bevis KS; Katre AA; Ziebarth A; Dobbin ZC; Alvarez RD; Zhang K; Conner M; Landen CN
    Clin Cancer Res; 2012 Feb; 18(3):869-81. PubMed ID: 22142828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells.
    Bhattacharya R; Mitra T; Ray Chaudhuri S; Roy SS
    J Cell Biochem; 2018 Apr; 119(4):3373-3383. PubMed ID: 29130517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for circulating cancer stem-like cells and epithelial-mesenchymal transition phenotype in the pleurospheres derived from lung adenocarcinoma using liquid biopsy.
    Mirza S; Jain N; Rawal R
    Tumour Biol; 2017 Mar; 39(3):1010428317695915. PubMed ID: 28347243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-to-Mesenchymal Transition in Paclitaxel-Resistant Ovarian Cancer Cells Is Downregulated by Luteolin.
    Dia VP; Pangloli P
    J Cell Physiol; 2017 Feb; 232(2):391-401. PubMed ID: 27198989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eliminating ovarian cancer stem cells: a potential therapeutic target for ovarian cancer chemoresistance.
    Wang X; Li X; Fu X; Bai M; Li X; Mei Q; Nie J; Wu Z; Han W
    Curr Protein Pept Sci; 2015; 16(4):270-8. PubMed ID: 25929861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress.
    Ip CK; Li SS; Tang MY; Sy SK; Ren Y; Shum HC; Wong AS
    Sci Rep; 2016 Jun; 6():26788. PubMed ID: 27245437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance.
    Mihanfar A; Aghazadeh Attari J; Mohebbi I; Majidinia M; Kaviani M; Yousefi M; Yousefi B
    J Cell Physiol; 2019 Apr; 234(4):3238-3253. PubMed ID: 30317560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
    Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
    J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
    Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
    Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.